SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1757)2/9/1999 12:43:00 AM
From: Rick Strange  Read Replies (2) | Respond to of 2205
 
It's my understanding that ATIS/S&N are involved with large animal cartilage studies now. These studies are preliminary to pilot human trials. Seems to me that the alliance for cartilage with S&N is de facto.

I'm anxious to see the impact of the much larger S&N salesforce on TransCyte. The Dermagraft numbers will be hard to read since Dermagraft used for the current trials will probably be included in those figures.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News